Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets.

McCann, Liza J; Hedrich, Christian M

McCann, Liza J; Hedrich, Christian M.

McCann LJ; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, UK; Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, UK.
Hedrich CM; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, UK; Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, UK. Electronic address: christian.hedrich@liverpool.ac.uk.

Clin Immunol ; 223: 108647, 2021 02.

Article en En | MEDLINE | ID: mdl-33310069

Asunto(s)

Antirreumáticos/uso terapéutico; Artritis Juvenil/tratamiento farmacológico; Enfermedades Musculoesqueléticas/tratamiento farmacológico; Enfermedades Reumáticas/tratamiento farmacológico; Atrofias Musculares Espinales de la Infancia/tratamiento farmacológico; Adolescente; Animales; Niño; Preescolar; Humanos; Terapia Molecular Dirigida; Medicina de Precisión

Palabras clave

Biomarkers; Child; Classification; Inflammation; Paediatric rheumatology; Stratified; Treatment

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Juvenil / Atrofias Musculares Espinales de la Infancia / Enfermedades Reumáticas / Enfermedades Musculoesqueléticas / Antirreumáticos Tipo de estudio: Prognostic_studies Límite: Adolescent / Animals / Child / Child, preschool / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google